An FDA hearing in late July may lead to a peptides boom. What consumers and investors need to know.

The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their ...

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider ...

The upcoming FDA advisory meeting is set to assess whether to allow pharmacies to produce seven different peptides.

By Sneha S K June 30 (Reuters) - U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to ...

Peptides are everywhere — promising to fix wrinkles, weight gain, and even torn ligaments. But are they safe? The FDA is ...

U.S. lawmakers are investigating whether several large drugmakers have been involved ​in clinical trials in China that helped ...

That’s why any entrepreneur in a consumer-facing enterprise should take note of the latest trends report from the brand and ...

When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set ...

Among the most common peptides in skincare are signal peptides. “These essentially tell the skin to make more collagen and ...

The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising ...

The reassurance about peptides is that the danger lives in the supply chain: buy clean, and the risk is gone. It is not. They ...